CVS
CVS
CVS
CVS NASDAQ
With media coverage debating CVS vs. UNH in terms of upside, CVS Health Corp's reported fundamentals offer clear context. The company generated full-year revenue of 402,067,000,000 against a market capitalization of 123,433,468,200. Furthermore, CVS trades at a PE ratio of 25.258485639686675, supported by an EPS TTM of 3.8448275862068964 and a free cash flow yield of 9.52577949195144%.
Based on zacks.comCVS vs. UNH: Which Health Insurance Stock Has More Upside Now?
Wall Street Isn't Giving Up on CVS Health -- and Its Valuation Looks Stronger Than Investors Think
Why CVS Health (CVS) is a Top Value Stock for the Long-Term
How CVS' Pharmacy & Consumer Wellness Is Positioned for H2 2026
CVS Pharmacy® and MinuteClinic® now offering updated flu vaccines nationwide
Which Turnaround Is Better for Retirees: CVS or INTC?
Revenue & Net Income (5Y)
EPS & Growth (5Y)
Free Cash Flow (5Y)
Capital Returns
Operating & Net Margin (5Y)
CapEx vs. Free Cash Flow (5Y)
Capital Allocation (5Y)
R&D and SG&A Intensity (5Y)
EBITDA (5Y)
Cost of Revenue (5Y)
Market Cap (5Y)
Ask Stonks with professional market data, charts beside chat, and your portfolio context.
Tape shows delayed public market data. Not investment advice.